Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03058289 |
| Title | A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 (IT-01) |
| Acronym | IT-01 |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Intensity Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| USC Norris | Los Angeles | California | 90033 | United States | Details | |
| USC HOAG | Newport Beach | California | 92663 | United States | Details | |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Baltimore | Maryland | 21205 | United States | Details | |
| UMASS Memorial Medical Center | Worcester | Massachusetts | 01655 | United States | Details | |
| Columbia University Medical Center | New York | New York | 10032 | United States | Details | |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111-2497 | United States | Details | |
| Center for Oncology and Blood Disorders | Houston | Texas | 77030 | United States | Details | |
| Princess Margaret Cancer Center - University Health Network | Toronto | Ontario | M5G 1Z5 | Canada | Details |